Clinical Outcomes of Individualized Botulinum Neurotoxin Type A Injection Techniques in Patients with Essential Blepharospasm
Youngje Sung, Sang Min Nam, Helen Lew
Korean J Ophthalmol. 2015;29(2):115-120.   Published online 2015 Mar 17     DOI:
Citations to this article as recorded by Crossref logo
Botulinum toxin for benign essential blepharospasm: A systematic review and an algorithmic approach
Y.A. Rayess, C.J. Awaida, S.F. Jabbour, A.S. Ballan, F.H. Sleilati, S.M. Abou Zeid, M.W. Nasr
Revue Neurologique.2021; 177(1-2): 107.     CrossRef
Blink index as a response predictor of blepharospasm to botulinum neurotoxin‐A treatment
Jeongkyeong Jang, Helen Lew
Brain and Behavior.2021;[Epub]     CrossRef
Postmarketing safety surveillance data reveals protective effects of botulinum toxin injections against incident anxiety
M. Axel Wollmer, Tigran Makunts, Tillmann H. C. Krüger, Ruben Abagyan
Scientific Reports.2021;[Epub]     CrossRef
Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm
Seunghyun Lee, Sangrye Park, Helen Lew
Korean Journal of Ophthalmology.2018; 32(1): 1.     CrossRef
A Retrospective Study on the Therapeutic Effect of Dextromethorphan on Essential Blepharospasm
学胜 郑
International Journal of Psychiatry and Neurology.2017; 06(03): 44.     CrossRef
Vitreous hemorrhage and Rhegmatogenous retinal detachment that developed after botulinum toxin injection to the extraocular muscle: case report
Dong Hyun Lee, Jinu Han, Sueng-Han Han, Sung Chul Lee, Min Kim
BMC Ophthalmology.2017;[Epub]     CrossRef